2
Disclosures
Feb 17, 2026 — Mar 13, 2026
Date Range
GROWTH
Market Segment

Disclosures

DateTypeHeadlinePDF
Mar 13 Other Reports Mid-Year Loss, Maintains Strong Cash Position Amid Ongoing Clinical Trials PDF
Mar 11 Earnings Stemrim Inc. Reports Earnings Results PDF

Disclosure Types

Other: 1 Earnings: 1